Exogenous nanomolar zinc ion (Zn2+) as a negative modulator of neuromuscular transmission via presynaptic mechanism in mouse diaphragm
- PMID: 40864346
- DOI: 10.1007/s10534-025-00740-3
Exogenous nanomolar zinc ion (Zn2+) as a negative modulator of neuromuscular transmission via presynaptic mechanism in mouse diaphragm
Abstract
Zinc (Zn2+) is the second most abundant trace element after iron, with most of it is stored in skeletal muscles. Although a large part of Zn2+ is tightly bound to metalloproteins, the small portion of free Zn2+ can participate in nerve signaling. Here we examined the effects of Zn2+ at nanomolar concentrations on neuromuscular transmission in the diaphragm, the main respiratory muscle. Zn2+ reduced spontaneous neurotransmitter release at both lowered and physiological external Ca2+ levels. Additionally, Zn2+ effectively decreased the probability of neurotransmitter release upon single nerve stimulation under lowered external Ca2+, and inhibited Ca2+-independent sucrose-induced exocytosis. At physiological external Ca2+ concentration, Zn2+ decreased neurotransmitter release during low-frequency stimulation. The reduction became increased during short trains of moderate-to-high frequency stimuli. Furthermore, Zn2+ diminished both neurotransmitter release and the participation of dye-labeled synaptic vesicles in exocytosis during prolonged nerve firing at moderate frequency. Zn2+ aggravated muscle fatigue and impaired contraction recovery upon nerve stimulation. This was linked to a reduction in peak inspiratory flow in mice, an indicator of diaphragm function, after injection of low-dose Zn2+. Our data suggest that at nanomolar concentrations, Zn2+ is a negative modulator of neuromuscular function.
Keywords: Muscle contraction; Neuromuscular junction; Neurotransmitter release; Synaptic vesicle; Zinc.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethical approval: Protocol of the experiments was approved by the Bioethics Committee of Kazan Federal Scientific Centre (protocol #23/7; May 12, 2023) and met the requirements of the EU Directive 2010/63/EU as well as the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (Council of Europe No 123, Strasbourg, 1985). Consent for publication: Not applicable.
References
-
- Anderson CT, Radford RJ, Zastrow ML et al (2015) Modulation of extrasynaptic NMDA receptors by synaptic and tonic zinc. Proc Natl Acad Sci U S A 112(20):E2705–E2714. https://doi.org/10.1073/pnas.1503348112 - DOI - PubMed - PMC
-
- Baraibar AM, Hernandez-Guijo JM (2020) Micromolar concentrations of Zn(2+) depress cellular excitability through a blockade of calcium current in rat adrenal slices. Toxicology 444:152543. https://doi.org/10.1016/j.tox.2020.152543 - DOI - PubMed
-
- Betz WJ, Bewick GS (1993) Optical monitoring of transmitter release and synaptic vesicle recycling at the frog neuromuscular junction. J Physiol 460(1):287–309. https://doi.org/10.1113/jphysiol.1993.sp019472 - DOI - PubMed - PMC
-
- Bukcharaeva EA, Kim KC, Moravec J, Nikolsky EE, Vyskocil F (1999) Noradrenaline synchronizes evoked quantal release at frog neuromuscular junctions. J Physiol 517(Pt 3):879–888. https://doi.org/10.1111/j.1469-7793.1999.0879s.x - DOI - PubMed - PMC
-
- Bukharaeva EA, Skorinkin AI, Samigullin DV, Petrov AM (2022) Presynaptic acetylcholine receptors modulate the time course of action potential-evoked acetylcholine quanta secretion at neuromuscular junctions. Biomedicines 10(8):1771. https://doi.org/10.3390/biomedicines10081771 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
